Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Cancer Res. 2018 Aug 30;78(21):6282–6296. doi: 10.1158/0008-5472.CAN-18-0894

Figure 6.

Figure 6.

MST-312 and Pt-ttpy treatment induces chromatin bridges in late mitosis in HT1080 cells. Cells in mitosis were stained with antibodies against LAP2 (in green) and α-Survivin (in red). A, Control cells (DMSO); B, MST-312-treated cells. C, Pt-ttpy-treated cells.